Trial Profile
Phase I study of Gemcitabine, Cisplatin and S-1 for advanced biliary tract cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer
- Focus Adverse reactions; Therapeutic Use
- 18 May 2012 Planned end date changed from 1 Sep 2013 to 1 Sep 2014 as reported by University Hospital Medical Information Network - Japan.
- 03 Oct 2011 Planned end date added Sep 2013 as reported by University Hospital Medical Information Network - Japan record.
- 03 Oct 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.